Policy Brief: Delivering healthy lives and well-being for women and girls
Policy & Practice Report
SAPPHIRE study: Strengthening China’s rural public health services for hypertension and diabetes care
Background Over the last few decades, the Chinese primary healthcare systemhas progressively weakened following economic liberalisation, rapid growth and changing consumer expectations. In 2009, the Chinese Government launched reforms to provide an essential public health service package’ for primary care activities, including hypertension and type 2 diabetes. Uptake of services varies and large quality gaps exist.
Aims The overall goal of this five-year project is to strengthen primary health care systems to enhance uptake of the government’s essential public health services package for hypertension and type 2 diabetes in three diverse regions in China.
Methods The SAPPHIRE study will be conducted in four phases, aligned with the Institute for Healthcare Improvement’s ‘Framework for Going to Full Scale’. Phase I (Understand): Rapid health system assessment to develop region- specific logic models. Phase II (Design): Develop a “change package” comprising of clin
Reducing salt consumption in China
Background Excess salt in the diet is associated with high blood pressure and increased risks of stroke, heart attack and kidney disease. This leads to serious health problems or premature death in hundreds of thousands of people in China every year. The problems with excess salt in take are particularly marked in China because food tends to be very salty. On average, Chinese people eat two and half times more salt each day than is recommended by the World Health Organization (WHO). Reducing salt in take has been clearly proven to lower blood pressure.Salt reduction is a focus for the Resolve To Save Lives (RTSL) initiative, which is commencing its salt reduction work in China.
Aims The overall goal of this five-year project is to support the implementation of the RTSL salt reduction program in China. Our work will help identify what works, what doesn’t and how to maximise impact on health with the resources available. Specifically, we will work with RTSL, the Chinese Center for
High-risk pregnancy and NCDs in India- policy and research recommendations
Policy & Practice Report
Reducing salt to save lives: Advocacy, partnerships and research
For more than a decade, The George Institute has championed global action that has the potential to save many millions of lives and billions of dollars in healthcare costs. Our researchers have generated evidence that shows the health benefits and cost-effectiveness of a range of interventions to reduce the amount of salt people eat, and can guide government, industry and consumer behaviour towards healthier societies.
Leads
this is another page 2
j,mhjkhj hjhjhhjhjhjhjm hjhjm
Child page 1
Child page 1
Child page 2
Child page 2
Clinical and community trials
About this study
Intracerebral haemorrhage (ICH), bleeding into the brain, is the most serious and least treatable form of stroke, accounting for at least 10% of the 20 million new strokes that occur in the world each year.
Patients fortunate enough to survive an ICH are at very high risk of another ICH as well as heart attacks and other serious heart-related events. Whilst there is strong evidence that these risks can be reduced by good control of blood pressure (BP), many patients do not receive any BP lowering treatment or that this treatment is inadequate.
TRIDENT aims to determine the benefits of using three different BP medications (each at half the normal dose) in a single pill on preventing another stroke. This capsule with the three medications, is called the Triple Pill. The study is hoping to enrol and treat 1500 people.
Recruitment criteria
Inclusion criteria
Adults with a history of ICH stroke
Average resting BP in the 130-160 mmHg range
Clinical and community trials
About this study
People with advanced kidney disease or those receiving dialysis often have other diseases related to the heart, brain and blood vessels, known as vascular disease (for example, heart attack, stroke and poor blood circulation). However, few treatments have been proven to prevent these conditions in people with advanced kidney disease. Blood thinners (medicines that prevent blood clots) are frequently used and proven to help other groups of people who are at high risk of vascular disease.
There is little understanding of whether blood thinners provide similar benefits in people with advanced kidney disease. The aim of the TRACK study is to find out whether a low dose of blood thinning medicine can reduce heart and vascular disease better than placebo (a look alike tablet that contains no active medication) in people with advanced kidney disease.
Recruitment criteria
Inclusion:
Age ≥18 years,
Advanced kidney disease (kidney failure on dialysis, or
Join Us: Strengthening Australia’s research capability
Background
Australia is a world leader in health and medical research, however an ongoing research barrier is the slow recruitment of research participants across the country.
Increasing community involvement in medical research is a key goal for the government’s “National One Stop Shop” for clinical trials.
Research registers are a proven way of connecting patients and researchers, but these registers typically address specific diseases, focus on people attending metropolitan centres of excellence, and can be difficult for patients to navigate.
Disease-agnostic research registers offer participants of all types a single point of access to research.
Aims
Join Us is a not-for-profit, disease-agnostic health research register dedicated to connecting everyday Australians with meaningful research opportunities.
Join Us aims to achieve better health and wellbeing for the Australian community by removing a major barrier to the recruitment of participant
Point Prevalence Program
The Point Prevalence Program (PPP) is a collaborative project between Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) and the Critical Care Division of The George Institute.
Aim
As a coordinated and validated project , the Point Prevalence Program provides infrastructure to conduct several multi-centre observational studies simultaneously on specified study days each year. The impetus for the PPP is to improve the efficiency of the collection of observational data that helps design clinical trial protocols for future ANZICS CTG studies. A further use of the PPP is that it can help with generating data to understand how research findings are translated into clinical practice.
Significance
The program facilitates collaborations amongst members of the CTG with an average of 44 ICUs participating each study day from a range of tertiary, metropolitan, regional-rural and private hospitals with an average recruitment per study day of more than 550 participants.